Nrf2 in toxic models of degenerative disorders: an approache to Parkinson's and huntington's disease

被引：0
|
作者：
Ali, S. F. [1 ]
Tobon-Velasco, J. C. [2 ,3 ]
Pedraza-Chaverri, J. [3 ]
Cuadrado, A. [4 ]
Maldonado, P. D. [2 ]
Santamaria, A. [1 ,2 ]
机构：
[1] NCTR, Div Neurotox, Neurochem Lab, Jefferson, AR USA
[2] MVS SSA, Inst Nacl Neurol & Neurocirugia, Lab Aminoacids Excitadores, Mexico City, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Dept Biol, Fac Quim, Mexico City, DF, Mexico
[4] Inst Invest Biomedades, Madrid, Spain
来源：
JOURNAL OF NEUROCHEMISTRY | 2013年 / 125卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [21] Disorders of movement scaling during gait in Parkinson's disease and Huntington's disease
    Morris, AE
    Iansek, R
    Bilney, B
    McGinley, J
    Georgiou-Karistianis, N
    Huxhamn, F
    MOVEMENT DISORDERS, 2006, 21 : S88 - S89
  • [22] Toxic Exposure to Endocrine Disruptors Worsens Parkinson's Disease Progression through NRF2/HO-1 Alteration
    D'Amico, Ramona
    Gugliandolo, Enrico
    Siracusa, Rosalba
    Cordaro, Marika
    Genovese, Tiziana
    Peritore, Alessio Filippo
    Crupi, Rosalia
    Interdonato, Livia
    Di Paola, Davide
    Cuzzocrea, Salvatore
    Fusco, Roberta
    Impellizzeri, Daniela
    Di Paola, Rosanna
    BIOMEDICINES, 2022, 10 (05)
  • [23] NRF2 Activation and Downstream Effects: Focus on Parkinson's Disease and Brain Angiotensin
    Parga, Juan A.
    Rodriguez-Perez, Ana I.
    Garcia-Garrote, Maria
    Rodriguez-Pallares, Jannette
    Labandeira-Garcia, Jose L.
    ANTIOXIDANTS, 2021, 10 (11)
  • [24] Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson's disease
    Bento-Pereira, Claudia
    Dinkova-Kostova, Albena T.
    MEDICINAL RESEARCH REVIEWS, 2021, 41 (02) : 785 - 802
  • [25] The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease
    Tufekci, Kemal Ugur
    Bayin, Ezgi Civi
    Genc, Sermin
    Genc, Kursad
    PARKINSONS DISEASE, 2011, 2011
  • [26] Tidegluib provides neuroprotection in Parkinson's Disease model through Nrf2/are pathway
    Armagan, Guliz
    Sevgili, Elvin
    Gurkan, Fulya Tuzcu
    Dagci, Taner
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 96 : S27 - S27
  • [27] Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
    Diguet, E
    Fernagut, PO
    Wei, X
    Du, YS
    Rouland, R
    Gross, C
    Bezard, E
    Tison, F
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (12) : 3266 - 3276
  • [28] Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
    Diguet, E
    Fernagut, PO
    Wei, X
    Du, Y
    Bezard, E
    Tison, F
    MOVEMENT DISORDERS, 2004, 19 : S388 - S388
  • [29] A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models
    Lee, Ji Ae
    Son, Hyo Jin
    Park, Ki Duk
    Han, Se Hee
    Shin, Nari
    Kim, Ji Hyun
    Kim, Hye Ri
    Kim, Dong Jin
    Hwang, Onyou
    NEUROTOXICITY RESEARCH, 2015, 28 (04) : 332 - 345
  • [30] A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson’s Disease Models
    Ji Ae Lee
    Hyo Jin Son
    Ki Duk Park
    Se Hee Han
    Nari Shin
    Ji Hyun Kim
    Hye Ri Kim
    Dong Jin Kim
    Onyou Hwang
    Neurotoxicity Research, 2015, 28 : 332 - 345
12345